Although previous studies also showed that IL‐25/IL‐33/TSLP was up‐regulated in alveolar milieu of IPF patients,16, 22, 29, 30 the clinical implications still remain poorly defined because of the small number of enrolled subjects. The gene discussed is IL33; the disease is idiopathic pulmonary fibrosis.